Bioline RX Ltd Sponsored ADR (BLRX) has released an update.
BioLineRx Ltd. has been granted an additional 180 days by Nasdaq to meet the $1.00 minimum bid price requirement, extending their deadline to May 12, 2025. This follows a previous notification that the company failed to comply based on the closing bid price of its American Depositary Shares. If BioLineRx can achieve the minimum bid price for 10 consecutive trading days before the new deadline, it will regain compliance with Nasdaq’s listing rules.
For further insights into BLRX stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- M&A News: Paramount’s (NASDAQ:PARA) Merger with Skydance May Get Delayed
- Ford (NYSE:F) Cuts Hours At German EV Plant
- Did Intel (NASDAQ:INTC) Win the “Server Recession?”
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
